| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
41,504,000 |
| Market
Cap: |
1.55(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$21.06 - $40.91 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 625 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
10,995 |
133,280 |
276,351 |
867,449 |
| Total Sell Value |
$400,850 |
$4,028,847 |
$7,154,366 |
$20,637,629 |
| Total People Sold |
2 |
4 |
4 |
6 |
| Total Sell Transactions |
2 |
8 |
13 |
39 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2023-01-09 |
4 |
AS |
$27.08 |
$488,554 |
D/D |
(17,834) |
102,798 |
|
-19% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-27 |
4 |
AS |
$23.63 |
$470,253 |
D/D |
(19,815) |
28,023 |
|
-1% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-27 |
4 |
OE |
$16.15 |
$320,012 |
D/D |
19,815 |
31,843 |
|
- |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-27 |
4 |
AS |
$23.65 |
$52,341 |
D/D |
(2,204) |
248,750 |
|
-1% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-23 |
4 |
AS |
$23.00 |
$114,747 |
D/D |
(4,989) |
28,023 |
|
-0% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-23 |
4 |
OE |
$16.15 |
$80,572 |
D/D |
4,989 |
33,012 |
|
- |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-23 |
4 |
AS |
$23.00 |
$3,381 |
D/D |
(147) |
250,954 |
|
-0% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-22 |
4 |
AS |
$23.00 |
$5,451 |
D/D |
(237) |
28,023 |
|
-3% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-22 |
4 |
OE |
$16.15 |
$3,828 |
D/D |
237 |
28,260 |
|
- |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-22 |
4 |
AS |
$23.00 |
$2,530 |
D/D |
(110) |
251,101 |
|
-3% |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-21 |
4 |
AS |
$23.11 |
$169,466 |
D/D |
(7,333) |
251,211 |
|
-4% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-21 |
4 |
AS |
$23.11 |
$1,076,926 |
D/D |
(46,600) |
28,023 |
|
-4% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-21 |
4 |
OE |
$16.15 |
$752,590 |
D/D |
46,600 |
74,623 |
|
- |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-20 |
4 |
AS |
$23.07 |
$216,281 |
D/D |
(9,375) |
258,544 |
|
-2% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-20 |
4 |
AS |
$23.08 |
$779,135 |
D/D |
(33,758) |
28,023 |
|
-2% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-20 |
4 |
OE |
$16.15 |
$545,192 |
D/D |
33,758 |
61,781 |
|
- |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-19 |
4 |
AS |
$23.01 |
$26,093 |
D/D |
(1,134) |
267,919 |
|
1% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-19 |
4 |
AS |
$23.04 |
$83,082 |
D/D |
(3,606) |
28,023 |
|
1% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-19 |
4 |
OE |
$16.15 |
$58,237 |
D/D |
3,606 |
31,629 |
|
- |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-13 |
4 |
AS |
$22.16 |
$3,582,984 |
D/D |
(161,687) |
28,023 |
|
3% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-13 |
4 |
OE |
$14.57 |
$2,441,404 |
D/D |
161,687 |
189,710 |
|
- |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-12 |
4 |
AS |
$22.01 |
$614,519 |
D/D |
(27,920) |
28,023 |
|
7% |
|
| Heffernan Michael Thomas |
Director |
– • – |
2022-12-12 |
4 |
OE |
$14.57 |
$421,334 |
D/D |
27,920 |
55,943 |
|
- |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-02 |
4 |
AS |
$23.07 |
$1,255,008 |
D/D |
(54,400) |
269,053 |
|
-0% |
|
| Ciaffoni Joseph |
President and CEO |
• • – |
2022-12-01 |
4 |
AS |
$22.47 |
$1,722,393 |
D/D |
(76,653) |
323,453 |
|
1% |
|
391 Records found
|
|
Page 3 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.28 (0.76%) 
